Related references
Note: Only part of the references are listed.Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Tara C. Anderson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation
Emily Baumrin et al.
BLOOD ADVANCES (2021)
VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients
Anne Conrad et al.
BMJ OPEN (2019)
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial
Adriana Bastidas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine
Ping Yang et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Immunobiology of Varicella-Zoster Virus Infection
Kerry J. Laing et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses
Lichen Jing et al.
JOURNAL OF IMMUNOLOGY (2016)
Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
Justyna Ogonek et al.
FRONTIERS IN IMMUNOLOGY (2016)
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination
Kareem Jamani et al.
BLOOD ADVANCES (2016)
Characterization of CMV-specific CD4*T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation
Mohammad Raeiszadeh et al.
HAEMATOLOGICA (2015)
Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay
Kazumi Hayashida et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Characterization of CMV-specific CD4*T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation
Mohammad Raeiszadeh et al.
HAEMATOLOGICA (2015)
Varicella-Zoster Virus-Specific, Cell-Mediated Immunity With Interferon-Gamma Release Assay After Vaccination of College Students With no or Intermediate IgG Antibody Response
Kihei Terada et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis—The Incidence Remains High
Ola Blennow et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Flow cytometric evaluation of lymphocyte transformation test based on 5-ethyny1-2′deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement
Fanny Poujol et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Broadly Reactive Human CD8 T Cells that Recognize an Epitope Conserved between VZV, HSV and EBV
Christopher Chiu et al.
PLOS PATHOGENS (2014)
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Insaf Salem Fourati et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Reconstitution of Protective Immune Responses against Cytomegalovirus and Varicella Zoster Virus Does Not Require Disease Development in Pediatric Recipients of Umbilical Cord Blood Transplantation
Natacha Merindol et al.
JOURNAL OF IMMUNOLOGY (2012)
High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation
Shih Hann Su et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis
Julia A. Brown et al.
BLOOD (2010)
IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies
G. N. Malavige et al.
BRITISH JOURNAL OF CANCER (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay
P. A. C. Maple et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Interferon-γ release assay: A simple method for detection of varicella-zoster virus-specific cell-mediated immunity
Naruhito Otani et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Recovery of Varicella-Zoster Virus-Specific T Cell Immunity after T Cell-Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation
Eva Distler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Humoral and cellular immunity to varicella-zoster virus: An overview
Ann M. Arvin
JOURNAL OF INFECTIOUS DISEASES (2008)
Seroprevalence of varicella antibodies among pregnant women in Lyon-France
M. Saadatian-Elahi et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2007)
Immune reconstitution following hematopoietic stem-cell transplantation
Michelle Geddes et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study
M Boeckh et al.
BLOOD (2006)
Seroprevalence of varicella in the French population
B Khoshnood et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience
JN Berman et al.
BONE MARROW TRANSPLANTATION (2006)
Decline in Varicella-Zoster Virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine
MJ Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
JW Gratama et al.
BLOOD (2001)
Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
DC Douek et al.
LANCET (2000)
Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation
TF Leung et al.
BONE MARROW TRANSPLANTATION (2000)
Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome
Y Koc et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
